Vaccine companies develop biological products that train the immune system to recognise and respond to infectious agents, cancer-associated targets and other disease-related antigens. Their work spans human health, veterinary medicine and preparedness for emerging pathogens.
This category includes companies working on:
Browse 61 UK vaccine companies below.
Non-profit partnership developing livestock health products for low-income markets
GALVmed is a non-profit public-private partnership facilitating the development and market access of vaccines, pharmaceuticals, and diagnostics for livestock diseases affecting…
Precision oncology drugs and vaccines for cold tumours
IngenOx Therapeutics Limited is a clinical-stage biopharmaceutical company developing precision oncology drugs and cancer vaccines for difficult-to-treat tumours. The company…
Thermostable vaccine platform eliminating cold chain dependency
Stablepharma is a clinical-stage biotechnology company developing fridge-free vaccines and biologicals using. Its technology reformulates temperature-sensitive products into…
Immuno-oncology therapies targeting the nfP2X7 cancer receptor
Biosceptre is a UK-headquartered clinical-stage biotechnology company developing cancer therapeutics based on its proprietary nfP2X7 platform. The nfP2X7 receptor is a…
T cell immunotherapies for infectious disease, cancer and autoimmunity
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific T cell immunotherapies for chronic infectious diseases, autoimmune conditions,…
Off-the-shelf cancer immunotherapies targeting solid tumours
Scancell is a clinical-stage biotech developing active immunotherapies and antibody-based therapeutics for cancer. Its pipeline spans DNA cancer vaccines, peptide immunotherapies…
Separation, purification, and sample preparation tools for life science workflows
Biotage GB is the UK subsidiary of Biotage AB, a Swedish life science tools group with manufacturing roots in Wales dating to 1969. Operating from facilities in Ystrad Mynach and…
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's…
Cell-based platform for next-generation mRNA medicines
Sensible Biotechnologies is a biotechnology company developing a cell-based platform for the design, optimisation, and manufacturing of high-quality mRNA. Using engineered living…
Phase 1 clinical research and bioanalytical services for drug development
Celerion is a contract research organisation specialising in early-stage clinical research for pharmaceutical and biotechnology clients. Operating from a dedicated Phase 1 clinic…
AAV gene therapy company targeting inherited and common retinal diseases
Beacon Therapeutics is a clinical-stage UK biopharma company developing adeno-associated virus (AAV) gene therapies for retinal diseases causing blindness. Its lead programme,…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen’s platform generates multivalent carbohydrate…